Immuneering Corporation (IMRX)

NASDAQ: IMRX · IEX Real-Time Price · USD

1.800

+0.030 (1.69%)

At close: Apr 19, 2024, 4:00 PM

1.770

-0.030 (-1.67%)

After-hours: Apr 19, 2024, 4:34 PM EDT

Immuneering Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	Current	2023	2022	2021	2020
Market Capitalization	53	215	128	419	-
Market Cap Growth	-	67.99%	-69.47%	-	-
Enterprise Value	-28	134	27	276	-36
PE Ratio	-4.02	-4.02	-2.53	-12.51	-
PS Ratio	-	-	404.05	201.67	-
PB Ratio	0.58	2.38	1.17	2.69	-
P/FCF Ratio	-4.36	-4.36	-2.86	-13.57	-
P/OCF Ratio	-4.39	-4.39	-2.90	-13.60	-
EV/Sales Ratio	-	-	86.38	132.51	-15.78
EV/EBITDA Ratio	-2.54	-2.54	-0.55	-8.18	2.15
EV/EBIT Ratio	-2.50	-2.50	-0.54	-8.14	2.14
EV/FCF Ratio	-2.72	-2.72	-0.61	-8.92	2.49
Debt / Equity Ratio	0.05	0.05	0.04	0.03	-0.03
Debt / EBITDA Ratio	-0.08	-0.08	-0.10	-0.16	-0.04
Debt / FCF Ratio	-0.09	-0.09	-0.11	-0.17	-0.04
Quick Ratio	10.92	10.92	13.10	26.53	16.66
Current Ratio	11.36	11.36	13.50	27.04	16.73
Asset Turnover	0	0	0.00	0.02	0.09
Return on Equity (ROE)	-52.50%	-52.50%	-39.70%	-53.50%	117.50%
Return on Assets (ROA)	-47.60%	-47.60%	-36.70%	-32.20%	-64.90%
Return on Capital (ROIC)	-61.46%	-61.46%	-45.12%	-21.00%	78.14%
Earnings Yield	-101.45%	-24.86%	-39.44%	-8.00%	-
FCF Yield	-93.55%	-22.92%	-35.02%	-7.37%	-
Buyback Yield / Dilution	-7.69%	-7.69%	-93.84%	-175.00%	-40.00%
Total Shareholder Return	-7.69%	-7.69%	-93.84%	-175.00%	-40.00%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).